ETopical – Lifestyle

Author: Amplia Therapuetics Limited

Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study

May 8, 2026
Accent Trial Mature Data Presented at International Conference

April 24, 2026
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models

March 26, 2026
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

March 23, 2026